Biosensor Technology
… technology to build proof-of-concept cartridge components for Archer’s biosensor devices. Mohammad talks about why this step is so important as the company looks to accelerate progress towards commercialising Archer’s innovative graphene-based biosensor technology. Quick facts: Archer Materials Ltd Price: 0.65 AUD …
Shedding New Light on GPCR Drug Discovery with a Novel Biosensor Technology | 9/2/2020
… signaling paradigms and are not sufficiently nuanced to address the various dimensions of GPCR signaling. In this GEN webinar, our expert panelists will introduce bioSensAll , an enhanced bystander bioluminescence resonance energy transfer (ebBRET)-based biosensor technology that addresses bottlenecks limiting current GPCR drug discovery and development efforts. Through various examples, our presenters will discuss how novel GPCR pharmacology concepts can be revealed by this new biosensor technology to advance drug …
Archer Materials announces proof-of-concept cartridge… Archer Materials announces proof-of-concept cartridge components for graphene biosensor device Archer Materials has progressed its graphene-based biosensor technology development by successfully prototyping key device hardware using additive manufacturing (3D printing). Graphene-based biosensor devices 2D printed on a circuit board that has been incorporated into the custom-designed and 3D printed cartridge made from ABS. The cartridge is opened and …
Efferent Labs and Gore Announce Development Collaboration | PR Newswire | 8/18/2020
… developing cutting edge materials for the life science industry,” said Bill Rader , CEO at Efferent. “We feel that they have the proper resources to help us continuously evolve the cellular environment in our implantable biosensor technology for use in both animal research and our future applications in human therapeutics.” “This collaborative effort is an inspiring opportunity to contribute Gore’s advanced material and biointerface capabilities to support Efferent Labs’ mission to …
Watching changes in plant metabolism — live | 8/16/2020
… at the University of Münster with the participation of the University of Bonn are studying key mechanisms in the regulation of energy metabolism. Now, for the first time, a new method of in vivo biosensor technology has enabled them to monitor in real time what effects environmental changes – for example, light, temperature, aridity, flooding or pest infestation – have on the central metabolism of the model plant Arabidopsis thaliana (thale cress …
in As-it-happens update ⋅ 15 August 2020 NEWS Watching changes in plant metabolism – live Science Daily Researchers use a new method of in vivo biosensor technology . Date: August 14, 2020; Source: University of Münster; Summary: Almost all life on Earth, … Flag as irrelevant Bayern’s brilliance, not Barca collapse, the story in historic Champions League contest ESPN The stadium – three-quarters empty, one-quarter filled with substitutes, coaches and media …
Watching changes in plant metabolism — live | 8/14/2020
Researchers use a new method of in vivo biosensor technology Credit: Plant Energy Biology Lab/Janina Steinbeck Almost all life on Earth, in particular our food and our health, depend on metabolism in plants. In order to understand how these metabolic processes function, researchers at the Institute of the Biology and Biotechnology of Plants at the University of Münster with the participation of the University of Bonn are studying key …
ivWatch Grows Biosensor Patent Portfolio Globally with Additional Grants | PR Newswire | 7/20/2020
… CE mark for its new disposable SmartTouch™ Sensor for the early detection of peripheral IV infiltration and extravasation events. To learn more about ivWatch, visit www.ivWatch.com . About ivWatch, LLC ivWatch, LLC is a medical biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk …
… in clinical development. Cambridge, Massachusetts-based Glympse Bio said Wednesday that it had raised a Series B financing round worth $46.7 million, which it will put toward a premarket approval-enabling study of its biosensor technology in NASH patients. Section 32 led the round, while Temasek, DNS Capital, New Leaf Venture Partners, Waterman Ventures and Catalio Capital Management also signed on as new investors. Existing investors taking part in the …
PathSensors receives expanded license from MIT for CANARY Technology | PRWeb | 7/9/2020
… President, Ted Olsen. “Now 8 years later, we are bringing CANARY™ to the healthcare field to provide rapid and highly sensitive detection solutions for a major public health crisis.” About CANARY™ CANARY™ is a biosensor technology that delivers extremely rapid detection of pathogens with high sensitivity and specificity. Originally developed by scientists at MIT–Lincoln Laboratory to combat bioterrorism threats, CANARY™ has been licensed and commercialized by PathSensors, Inc. About …
NEWPORT NEWS, Va. ivWatch, LLC , a pioneer in biosensor technology , has received FDA clearance for its new SmartTouch TM disposable sensor for the early detection of peripheral IV infiltration and extravasation events. This new FDA clearance expands the ivWatch® sensor portfolio to provide hospitals, infusion centers, and other healthcare facilities with complementary sensor solutions to help improve patient safety and reduce the risks associated with IV therapy. With an estimated …
ivWatch SmartTouch™ Sensor Receives FDA Clearance | 7/7/2020
ivWatch SmartTouch™ Sensor Receives FDA Clearance Wednesday, July 8, 2020 LinkedIn Email ivWatch, LLC , a pioneer in biosensor technology , announced it has received FDA clearance for their new SmartTouch TM disposable sensor for the early detection of peripheral IV infiltration and extravasation events. This new FDA clearance expands the ivWatch® sensor portfolio to provide hospitals, infusion centers, and other healthcare facilities with complementary sensor solutions to help improve patient safety …
NEWPORT NEWS, Va. , July 7, 2020 /PRNewswire/ – ivWatch, LLC , a pioneer in biosensor technology , has received FDA clearance for its new SmartTouch TM disposable sensor for the early detection of peripheral IV infiltration and extravasation events. This new FDA clearance expands the ivWatch® sensor portfolio to provide hospitals, infusion centers, and other healthcare facilities with complementary sensor solutions to help improve patient safety and reduce the risks associated with IV …
ivWatch SmartTouch(TM) Sensor Receives FDA Clearance for Continuous IV Site Monitoring | 7/7/2020
ivWatch SmartTouch(TM) Sensor Receives FDA Clearance for Continuous IV Site Monitoring By ivWatch, LLC The ivWatch SmartTouch™ Sensor is cleared to monitor the IV sites of all age groups. By ivWatch, LLC Save NEWPORT NEWS, Va. , July 7, 2020 /PRNewswire/ – ivWatch, LLC , a pioneer in biosensor technology , has received FDA clearance for its new SmartTouch TM disposable sensor for the early detection of peripheral IV infiltration and extravasation events …
ivWatch SmartTouch(TM) Sensor Receives FDA Clearance for Continuous IV Site Monitoring | 7/7/2020
… By ivWatch, LLC The ivWatch SmartTouch™ Sensor is cleared to monitor the IV sites of all age groups. By ivWatch, LLC Save NEWPORT NEWS, Va. , July 7, 2020 /PRNewswire/ – ivWatch, LLC , a pioneer in biosensor technology , has received FDA clearance for its new SmartTouch TM disposable sensor for the early detection of peripheral IV infiltration and extravasation events. This new FDA clearance expands the ivWatch® sensor portfolio to provide hospitals …
PathSensors Enters Merger Agreement With Smiths Detection | 7/2/2020
… Smiths advanced biological detection capabilities to both serve its existing customer base and also expand into adjacent security markets including food and agricultural quality assurance. Founded in 2010, PathSensors utilizes CANARY, a cell-based biosensor technology that delivers extremely rapid detection of pathogens at previously unseen levels of sensitivity and specificity. PathSensors licensed and subsequently commercialized CANARY — originally developed by scientists at MIT’s Lincoln Laboratories to combat bioterrorism threats — for …
… to Therapies” session and the “Recent Biomarker Discovery Techniques” session of the meeting and titled, respectively: “Digital Nanoneedle Biosensors Enable Comprehensive Monitoring of Cytokines Related to Systemic Inflammatory Response to Immunotherapies” and “Digital Nanoneedle Biosensor Technology for Proteome-Wide Biomarker Discovery”. “Monitoring the cytokine response during immunotherapy is technically challenging due to the wide range of biomarker concentrations, small sample volumes, and long assay times. NanoMosaic’s Tessie ™ system overcomes these …
… patent applications which will be filed shortly. The company has also developed an extensive portfolio of trade secrets related to delivering affordable, reproducible, ultra-highly sensitive and specific biosensors. Mr. Joshi further commented, “Our biosensor technology is designed to adapt to a wide variety of health conditions. As an example, shortly after the Covid-19 pandemic began, we demonstrated the flexibility and scalability of our platform for the potential direct …
PathSensors Enters Merger Agreement With Smiths Detection | The Wapakoneta Daily News | 7/1/2020
… Smiths advanced biological detection capabilities to both serve its existing customer base and also expand into adjacent security markets including food and agricultural quality assurance. Founded in 2010, PathSensors utilizes CANARY, a cell-based biosensor technology that delivers extremely rapid detection of pathogens at previously unseen levels of sensitivity and specificity. PathSensors licensed and subsequently commercialized CANARY — originally developed by scientists at MIT’s Lincoln Laboratories to combat bioterrorism threats — for …
An Activity-Based Fluorogenic Probe Enables Cellular and in Vivo Profiling of Carboxylesterase Isozymes Shi-Yu Liu Shi-Yu Liu Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, International Joint Research Center for Intelligent Biosensor Technology and Health, and Chemical Biology Center, College of Chemistry, Central China Normal University, Wuhan 430079, P.R. China Ren-Yu Qu Ren-Yu Qu Key Laboratory of Pesticide & Chemical Biology of Ministry of …
Oral Cancer Rapid Test Kit Market Explored in Latest Research | Wordpress.com | 6/19/2020
… The great value that point-of-care diagnostics play in general well-being of patients offers a broad impetus also to the expansion of the oral cancer rapid test kit market. Advances made in biosensor technology has helped stakeholder see new revenues streams in the market. A case in point is lab-on-a-chip. Manufacturers in the oral cancer rapid test kits market over the years have put increasing …
Council Post: Why Disciplined Innovation Matters Most Now | Forbes | 6/19/2020
… manufacturing. A double dose of disciplined innovation will go a long way in helping the world right now. Think about all the benefits that could come from innovations such as wearable patches embedded with biosensor technology to monitor a patient’s vital signs remotely, along with patches equipped with acoustic and audio sensors to interpret cough patterns and respiratory rates, as well as heart and lung sounds. Expect to see an …
… agreement to explore implantable electronic systems to affect the future of patient care. An expert in micro technologies, Dr. Teshima will be working full-time at TUM in the area of advanced neuroelectronics and biosensor technology . Dr. Teshima began his three-year appointment on March 1, 2020. Dr. Teshima’s research has covered a broad range of topics that overlap with the MEI Lab’s mission, including micro bio-nano interfaces, parasitology …
… agreement to explore implantable electronic systems to affect the future of patient care. An expert in micro technologies, Dr. Teshima will be working full-time at TUM in the area of advanced neuroelectronics and biosensor technology . Dr. Teshima began his three-year appointment on March 1, 2020. Dr. Teshima’s research has covered a broad range of topics that overlap with the MEI Lab’s mission, including micro bio-nano interfaces, parasitology …
Archer Materials announces progress with its graphene biosensors for disease detection | 6/12/2020
Archer Materials announces progress with its graphene… Archer Materials announces progress with its graphene biosensors for disease detection Archer Materials has reported that it is making progress with its graphene-based biosensor technology with recent work spanning technology development, commercialization and patent prosecution. This work includes the development of portable hardware to interface with Archer’s biosensor technology with simplified sensor response. Archer has also formulated and successfully tested inkjet-printable …
Biosensors
Better Biosensor Technology Created for Stem Cells | 11/15/2019
… biosensors. Image: Letao Yang, KiBum Lee, Jin-Ho Lee and Sy-Tsong (Dean) Chueng Todd Bates 848-932-0550 A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer’s and Parkinson’s diseases and other neurological disorders. The technology, which features a unique graphene and gold-based platform and high-tech imaging, monitors the fate of stem cells by detecting genetic material …
Better biosensor technology created for stem cells | 11/11/2019
November 11, 2019 / Rutgers University Rutgers innovation may help guide treatment of Alzheimer’s, Parkinson’s diseases This unique biosensing platform consists of an array of ultrathin graphene layers and gold nanostructures. The platform, combined with high-tech imaging (Raman spectroscopy), detects genetic material (RNA) and characterizes different kinds of stem cells with greater reliability, selectivity and sensitivity than today’s biosensors. A Rutgers-led team has created better biosensor technology that may …
Patient Monitoring
NEWPORT NEWS, Va.–(BUSINESS WIRE)–Jun 27, 2019– ivWatch , a biosensor technology company focused on improving patient safety and the effectiveness of intravenous (IV) therapy, expands their foothold in Australia and Europe by securing two … ensures medical professionals are certain they are providing highly effective patient monitoring during IV therapy administration.” The granting of Australian Patent No. 2018211312 is for a technology regarding how an ivWatch sensor head adheres to …
VitalConnect Secures Fifth U.S. FDA Clearance for Patient Monitoring Device The VitalPatch wearable biosensor will include 5-day wear duration in alignment with nation’s average hospital stay News provided by 10:00 ET Share this article SAN JOSE, Calif. , Dec. VitalConnect, Inc., a leader in wearable biosensor technology for wireless monitoring in hospital and remote patient populations, today announced its fifth 510(k) market clearance from the U.S. Food and Drug …
Patient Safety
NEWPORT NEWS, Va.–(BUSINESS WIRE)–Jun 27, 2019– ivWatch , a biosensor technology company focused on improving patient safety and the effectiveness of intravenous (IV) therapy, expands their foothold in Australia and Europe by securing two patent grants for core product technologies. Additionally, the ivWatch European Patent No. 2830488 announced in October 2018 has been validated in six nations resulting in the following rights: Belgium Patent No. EP2830488 United Kingdom Patent …
ivWatch Announces Expansion into Canada with Distributor Roxon | Business Wire | 5/7/2019
HAMPTON, Va.–( BUSINESS WIRE )– ivWatch , a leading provider of biosensor technology focused on improving patient safety and the effectiveness of intravenous (IV) therapy, has entered into an exclusive distribution agreement with Roxon medi-tech , a distributor of specialized medical equipment based in Montreal, Quebec. The agreement includes the rights to distribute the ivWatch Model 400, the only device to receive clearance, globally, to offer early detection of infiltrations/extravasations, in …
Food and Drug Administration
VitalConnect Secures Fifth U.S. FDA Clearance for Patient Monitoring Device The VitalPatch wearable biosensor will include 5-day wear duration in alignment with nation’s average hospital stay News provided by 10:00 ET Share this article SAN JOSE, Calif. , Dec. VitalConnect, Inc., a leader in wearable biosensor technology for wireless monitoring in hospital and remote patient populations, today announced its fifth 510(k) market clearance from the U.S. Food and Drug …
SAN JOSE, Calif. , Dec. VitalConnect, Inc., a leader in wearable biosensor technology for wireless monitoring in hospital and remote patient populations, today announced its fifth 510(k) market clearance from the U.S. Food and Drug Administration. This clearance extends the wear duration for the company’s existing Class 2 wearable biosensor, the VitalPatch ® , by 25 percent from 96 hours (four days) to 120 hours (five days). VitalPatch The national average for …
Diabetes Management
… Bio Sensor Technology for Citrus Greening Disease Cepheid Became an Indirect Wholly Owned Subsidiary of Danaher PathSensors, Inc Develops Universal BioSensor Technology PathSensors Introduces New High Speed Diagnostic Plant Pathogen Assays Smith Detection Enhances IONSCAN … Pump and Continuous Glucose Monitoring System Received FDA Approval for Diabetes Management in Children Ages Two and Older New Drger Tcore Sensor for Non-Invasive and Accurate Measurement of Body’s Core Temperature Nanomedical Diagnostics, Inc …
Global $25 Billion Biosensors Market, 2022 | PR Newswire | 10/19/2017
… Bio Sensor Technology for Citrus Greening Disease Cepheid Became an Indirect Wholly Owned Subsidiary of Danaher PathSensors, Inc Develops Universal BioSensor Technology PathSensors Introduces New High Speed Diagnostic Plant Pathogen Assays Smith Detection Enhances IONSCAN … Pump and Continuous Glucose Monitoring System Received FDA Approval for Diabetes Management in Children Ages Two and Older New Drger Tcore Sensor for Non-Invasive and Accurate Measurement of Body’s Core Temperature Nanomedical Diagnostics, Inc …
Medical Diagnostics
… is estimated the largest end-user for Biosensors. Key Business Trends Abbott’s FreeStyle Libre Glucose Monitoring System Reimbursement in Japan Nanomedical Diagnostics’ New NHS Agile Biosensor Chip for Use on Agile R100 Label-free Personal … Indirect Wholly Owned Subsidiary of Danaher PathSensors, Inc Develops Universal BioSensor Technology PathSensors Introduces New High Speed Diagnostic Plant Pathogen Assays Smith Detection Enhances IONSCAN 600 Detector Capabilities MBiotech Acquired by Integrated DNA Technologies Biosensors …
Global $25 Billion Biosensors Market, 2022 | PR Newswire | 10/19/2017
… is estimated the largest end-user for Biosensors. Key Business Trends Abbott’s FreeStyle Libre Glucose Monitoring System Reimbursement in Japan Nanomedical Diagnostics’ New NHS Agile Biosensor Chip for Use on Agile R100 Label-free Personal … Indirect Wholly Owned Subsidiary of Danaher PathSensors, Inc Develops Universal BioSensor Technology PathSensors Introduces New High Speed Diagnostic Plant Pathogen Assays Smith Detection Enhances IONSCAN 600 Detector Capabilities MBiotech Acquired by Integrated DNA Technologies Biosensors …
Thermo Fisher
… Thermo Fisher Scientific PathSensors and USDA’s Agricultural Research Service team to Develop Bio Sensor Technology for Citrus Greening Disease Cepheid Became an Indirect Wholly Owned Subsidiary of Danaher PathSensors, Inc Develops Universal BioSensor Technology PathSensors Introduces New High Speed Diagnostic Plant Pathogen Assays Smith Detection Enhances IONSCAN 600 Detector Capabilities MBiotech Acquired by Integrated DNA Technologies Biosensors International Enters into Distribution Agreement with CORDIS BioProfile FLEX2, the Next Addition to …
Global $25 Billion Biosensors Market, 2022 | PR Newswire | 10/19/2017
… Thermo Fisher Scientific PathSensors and USDA’s Agricultural Research Service team to Develop Bio Sensor Technology for Citrus Greening Disease Cepheid Became an Indirect Wholly Owned Subsidiary of Danaher PathSensors, Inc Develops Universal BioSensor Technology PathSensors Introduces New High Speed Diagnostic Plant Pathogen Assays Smith Detection Enhances IONSCAN 600 Detector Capabilities MBiotech Acquired by Integrated DNA Technologies Biosensors International Enters into Distribution Agreement with CORDIS BioProfile FLEX2, the Next Addition to …
About:
Editor:
